A study on relapse/re-infection rate of Plasmodium vivax malaria and identification of the predominant genotypes of P. vivax in two endemic districts of Nepal

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Manandhar, Sulochana ^a   Bhusal, Chop L ^b   Ghimire, Umesh ^b   Singh, Shankar P ^b   Karmacharya, Dibesh B ^a   Dixit, Sameer M ^a  

^a Center for Molecular Dynamics Nepal   (Nepal)

^b Minister for Health and Population Nepal   (Nepal)

Author keywords

Circumsporozoite protein; Genotypes; Nepal; Plasmodium vivax; Relapse reinfection rate

Indexed keywords

CHLOROQUINE; CIRCUMSPOROZOITE PROTEIN; PRIMAQUINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DISEASE TRANSMISSION; ENDEMIC DISEASE; FEMALE; FOLLOW UP; GENOTYPE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPAL; OBSERVATIONAL STUDY; PARASITE ISOLATION; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; RECURRENT INFECTION; RELAPSE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DNA FINGERPRINTING; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA, VIVAX; MALE; MIDDLE AGED; NEPAL; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROSPECTIVE STUDIES; PROTOZOAN PROTEINS; RECURRENCE; YOUNG ADULT;

EID: 84884667808     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-324     Document Type: Article

References (35)

1. Ministry of Health, Nepal, Annual Report 2010/2011 Kathmandu: Department of Health Services 2011
2. Ministry of Health, Nepal, Nepal Malaria Strategic Plan 2011-2016 (Revised Version) Kathmandu, Nepal: Department of Health Services, Epidemiology & Disease Control Division Teku 2011
3. Genetic diversity of Plasmodium vivax merozoite surface protein-3alpha (Pvmsp-3alpha) gene in Jhapa District of Nepal. Adhikari M, Ranjitkar S, Schousboe ML, Alifrangis M, Imwong M, Bhatta DR, Banjara MR, Southeast Asian J Trop Med Public Health 2012 43 280 286 23082580
4. Characteristics and risk factors of Plasmodium falciparum malaria in Eastern and Central Nepal. Banjara MR, Sirawaraporn W, Petmitr S, Imwong M, Joshi AB, Chavalitshewinkoon-Petmitr P, Kathmandu Univ Med J (KUMJ) 2009 7 378 382
5. Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar. Kim TS, Kim HH, Lee SS, Na BK, Lin K, Cho SH, Kang YJ, Kim DK, Sohn Y, Kim H, Lee HW, Malar J 2010 9 195 10.1186/1475-2875-9-195 20615261
6. Molecular analysis of Plasmodium vivax relapses using the MSP1molecule as a genetic marker. Kirchgatter K, del Portillo HA, J Infect Dis 1998 177 511 515 10.1086/517389 9466551 (Pubitemid 28063789)
7. Genetic polymorphism in Plasmodium falciparum vaccine candidate antigens. Mahajan RC, Farooq U, Dubey ML, Malla N, Indian J Pathol Microbiol 2005 48 429 438 16366089 (Pubitemid 41769516)
8. Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras. Lopez AC, Ortiz A, Coello J, Sosa-Ochoa W, Torres RE, Banegas EI, Jovel I, Fontecha GA, Malar J 2012 26 391
9. Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immonodominant epitope. Arnot DE, Barnwell JW, Tam JP, Nussenzweig V, Nussenzweig RS, Science 1985 230 815 817 10.1126/science.2414847 2414847
10. Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Rosenberg R, Wirtz RA, Lanar DE, Sattabongkot J, Hall T, Waters AP, Prasittisuk C, Science 1989 245 973 976 10.1126/science.2672336 2672336 (Pubitemid 19224827)
11. Wide distribution of the variant form of the human malaria parasite Plasmodium vivax. Qari SH, Goldman IF, Povoa MM, Oliveira S, Alpers MP, Lal AA, J Biol Chem 1991 266 16297 16300 1885563 (Pubitemid 21907794)
12. A study of polymorphism in the circumsporozoite protein of human malaria parasites. Qari SH, Collins WE, Lobel HO, Taylor F, Lal AA, Am J Trop Med Hyg 1994 50 45 51 8304571 (Pubitemid 24059985)
13. Distribution of Plasmodium vivax variants (VK210, VK247 and P. vivax-like) in three endemic areas of Amazonian Brazil and their correlation with chloroquine-treatment. Machado RLD, Póvoa MM, Trans R Soc Trop Med Hyg 2000 94 377 381 10.1016/S0035-9203(00)90110-X 11127238 (Pubitemid 30662343)
14. Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in Southern Mexico. Gonzalez-Ceron L, Rodríguez MH, Entel JC, Villarreal C, Kain KC, Hernandez JE, Infect Immun 1999 67 410 412 9864243 (Pubitemid 29021676)
15. Correlation between Plasmodium vivax variants in Belém, Pará State, Brazil and symptoms and clearence of parasitemia. Machado RLD, Figueriredo-Filho AF, Calvosa VSP, Nascimento JM, Póvoa MM, J Infect Dis 2003 7 175 177
16. Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences? Souza-Neiras WC, Storti-Melo LM, Cassiano GC, Couto VS, Couto AA, Soares IS, Malar J 2010 9 178 10.1186/1475-2875-9-178 20573199
17. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Snounou G, Viriyakosol S, Zhu XP, Jarra W, Pinheiro L, do Rosario VE, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 61 315 320 10.1016/0166-6851(93)90077-B 8264734
18. Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Imwong M, Pukrittayakamee S, Grüner AC, Rénia L, Letourneur F, Looareesuwan S, White NJ, Snounou G, Malar J 2005 4 20 10.1186/1475-2875-4-20 15854233 (Pubitemid 40918738)
19. Determinants of relapse periodicity in Plasmodium vivax malaria. White NJ, Malar J 2011 10 297 10.1186/1475-2875-10-297 21989376
20. Genotyping of Plasmodium vivax reveals both short and long latency relapse patterns in Kolkata. Kim JR, Nandy A, Maji AK, Addy M, Dondorp AM, Day NP, Pukrittayakamee S, White NJ, Imwong M, PLoS One 2012 7 39645 10.1371/journal.pone.0039645 22808048
21. Relapse pattern of Plasmodium vivax in Mumbai: a study of 283 cases of vivax malaria. Gogtay NJ, Desai S, Kadam VS, Kamtekar KD, Dalvi SS, Kshirsagar NA, J Assoc Phys India 2000 48 1085 1086
22. Studies on the Plasmodium vivax relapse pattern in Delhi, India. Adak T, Sharma VP, Orlov VS, Am J Trop Med Hyg 1998 59 175 179 9684649 (Pubitemid 28304818)
23. Plasmodium vivax polymorphism in a clinical drug trial. Adak T, Valecha N, Sharma VP, Clin Diagn Lab Immunol 2001 8 891 894 11527798 (Pubitemid 32868302)
24. World Health Organization, Guidelines for the treatment of malaria. Second edition 1211 Geneva 27, Switzerland: WHO Press, World Health Organization, 20, avenue Appi 2010
25. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL, Jolley D, Ringwald P, Biggs BA, Am J Trop Med Hyg 2007 76 203 207 17297026 (Pubitemid 351627764)
26. Primaquine therapy for malaria. Baird JK, Hoffman SL, Clin Infect Dis 2004 39 1336 1345 10.1086/424663 15494911 (Pubitemid 39458520)
27. Molecular characterization of Plasmodium vivax clinical isolates in Pakistan and Iran using pvmsp-1, pvmsp-3alpha and pvcsp genes as molecular markers. Zakeri S, Raeisi A, Afsharpad M, Kakar Q, Ghasemi F, Atta H, Zamani G, Memon MS, Salehi M, Djadid ND, Parasitol Int 2010 59 15 21 10.1016/j.parint. 2009.06.006 19545647
28. Genetic diversity of Plasmodium vivax Pvcsp and Pvmsp1 in Guyana, South America. Bonilla JA, Validum L, Cummings R, Palmer CJ, Am J Trop Med Hyg 2006 75 830 835 17123973 (Pubitemid 351627526)
29. Genetic diversity of Plasmodium vivax in Kolkata, India. Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, Maji A, Addy M, Day NP, White NJ, Pukrittayakamee S, Malar J 2006 5 71 10.1186/1475-2875-5-71 16907979 (Pubitemid 44357748)
30. Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand. Cui L, Mascorro CN, Fan Q, Rzomp KA, Khuntirat B, Zhou G, Chen H, Yan G, Sattabongkot J, Am J Trop Med Hyg 2003 68 613 619 12812356 (Pubitemid 38240504)
31. Genetic diversity of Plasmodium vivax isolates from Azerbaijan. Leclerc MC, Menegon M, Cligny A, Noyer JL, Mammadov S, Aliyev N, Gasimov E, Majori G, Severini C, Malar J 2004 3 40 10.1186/1475-2875-3-40 15535878 (Pubitemid 40132146)
32. Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. Kain KC, Brown AE, Webster HK, Wirtz RA, Keystone JS, Rodrigues MH, Kinahan J, Rowland M, Lanar DE, J Clin Microbiol 1992 30 1863 1866 1629344
33. The population dynamics in mosquitoes and humans of two Plasmodium vivax polymorphs distinguished by different circumsporozoite protein repeat regions. Burket TR, Wirtz RA, Paru R, Garner P, Alpers MP, Am J Trop Med Hyg 1992 47 778 786 1471735 (Pubitemid 23019147)
34. Variants of the Plasmodium vivax circumsporozoite protein (VK210 and VK247) in Colombian isolates. Gonzalez JM, Hurtado S, Arevalo-Herrera M, Herrera S, Mem Inst Oswaldo Cruz 2001 96 709 712 10.1590/S0074-02762001000500023 11500776 (Pubitemid 33704179)
35. Different prevalence of Plasmodium vivax phenotypes VK210 and VK247 associated with distribution of Anopheles albimanus and Anopheles psedopunctipennis in Mexico. Rodriguez MH, Gonzalez-Ceron L, Hernandez JE, Nettel JA, Villarreal C, Kain KC, Wirtz RA, Am J Trop Med Hyg 2000 62 122 127 10761736 (Pubitemid 30180362)